BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

  June 16, 2026

   · 

  5 min read
• Press Releases

  BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

  June 16, 2026

   · 

  8 min read
• Press Releases

  Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

  June 16, 2026

   · 

  8 min read
• Press Releases

  Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

  June 16, 2026

   · 

  4 min read
• Press Releases

  ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

  June 16, 2026

   · 

  4 min read
• Press Releases

  Sanuwave Health Updates Second Quarter 2026 Guidance

  June 16, 2026

   · 

  3 min read
• Press Releases

  Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

  June 16, 2026

   · 

  6 min read
• Press Releases

  MultiValent Biotherapies Launches with $27 Million Series A Financing to Advance Development of Targeted Prostate Cancer Drug Conjugate

  June 16, 2026

   · 

  3 min read
• Press Releases

  Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

  June 16, 2026

   · 

  7 min read
• Press Releases

  Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium

  June 16, 2026

   · 

  6 min read